As de-methylation at enhancers is often associated with the binding of transcription factors during carcinogenesis [11, 12], we investigated whether those hypo-methylated enhancers were bound by TEAD4 by analyzing the previously published TEAD4 ChIP-seq data in two gastric cancer cell lines [13]. The gene discussed is TEAD4; the disease is gastric cancer.